Wencai Jiang

Mr. Wencai Jiang

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2024 in Vascular Health and Risk Management
Verified
Journal Article
Open access
PDF file
LFLijuan Fu
Lijuan Fu
RZRui Zhou
Rui Zhou
WJWencai Jiang
Wencai Jiang
LLLan Lan
Lan Lan
XCXuemeng Chen
Xuemeng Chen
XZXianjie Zhang
Xianjie Zhang
Background: While general anesthesia has been widely used in endovascular thrombectomy for acute ischemic stroke (AIS), the optimal anesthesia medication for hemodynamic management remains unclear. Purpose: To compare the effects of remimazolam and propofol on endovascular thrombectomy for AIS. Methods: This study is a single-center, double-blind and randomized controlled trial. Eligible patients will be randomly allocated into the remimazolam group and propofol group. Remimazolam and propofol will be administered to induce and maintain anesthesia respectively. The primary outcome is the incidence of intraoperative hypotension. The secondary outcomes include frequency of hypotension, the largest difference value of mean arterial pressure (MAP), dosage of vasopressors, extubation time, operation time, modified thrombolysis in cerebral infarction (mTICI) level, National Institutes of Health Stroke Scale (NIHSS) score and modified Rankin scale (mRS) score. Conclusion: This study evaluates the influences of remimazolam versus propofol on endovascular therapy for AIS patients. Results of this study are expected to provide more evidence of the choice of anesthetics in this kind of operation. Trial Registration: This study has been registered at the Chinese Clinical Trial Registry (ChiCTR2300076880).

1 January 2025 in Medical Devices: Evidence and Research
Verified
Journal Article
Open access
PDF file
WJWencai Jiang
Wencai Jiang
KKKang Kang
Kang Kang
XZXinyu Zhou
Xinyu Zhou
XCXuemeng Chen
Xuemeng Chen
HYHai Yu
Hai Yu
XZXianjie Zhang
Xianjie Zhang
Purpose: Lung ultrasound (LUS) is increasingly utilized in the field of anesthesiology due to its focused, quick application and the advantage of not exposing patients to ionizing radiation. This study aims to analyze the status and trends in this area from a macroscopic perspective. Methods: A bibliometric analysis was conducted using the Web of Science (WoS) Core Collection. The analysis and visualization were performed using WoS, Excel, VOSviewer, and CiteSpace. Parameters such as publications, countries, institutions, journals, and keywords were analyzed. Results: A total of 133 articles published over the last 10 years were analyzed to clarify the current status and future trends on the use of LUS in anesthesiology. The number of publications increased markedly from May 1, 2014, to April 30, 2024. China is the highest productive country, while the USA had the highest number of citations. In the institution, Seoul National University in South Korea published the most articles and had the highest number of citations. Kim Jin-Tae emerged as the most prolific and influential author. BMC Anesthesiology and the Journal of Cardiothoracic and Vascular Anesthesia were identified as the most popular journals in the field. Keywords such as “atelectasis”, “mechanical ventilation”, and “pulmonary complications” were closely related to the use of LUS in anesthesiology. Conclusion: This study provides a comprehensive analysis of research on the use of LUS in anesthesiology, highlighting the growing interest in LUS and its relevance to pulmonary complications.

12 December 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
WJWencai Jiang
Wencai Jiang
YPYanhua Peng
Yanhua Peng
XCXuemeng Chen
Xuemeng Chen
LFLijuan Fu
Lijuan Fu
WZWenhu Zhai
Wenhu Zhai
YZYukai Zhou
Yukai Zhou
Background: Supraclavicular brachial plexus block (SCB) is a common regional analgesic technique for upper limb fracture surgery, but it often leads to rebound pain. Our primary aim is to determine whether different administration methods of esketamine can reduce rebound pain in patients undergoing SCB for upper limb fracture surgery. Methods/design: This study is designed as a single-centre, double-blinded, prospective, randomised controlled trial. Patients undergoing upper limb fracture surgery, who plan to use a tourniquet, aged 18–60 years, with a body mass index of 18–30 kg/m 2 and an American Society of Anaesthesiologists classification of I–III will be randomised into three groups after providing written informed consent: group N (perineural esketamine/ropivacaine); group V (intravenous esketamine/perineural ropivacaine); and group C (perineural ropivacaine). The primary outcome will be the percentage of patients experiencing rebound pain within 24 hours postoperatively. Secondary outcomes include the Numeric Rating Scale (NRS) score of rebound pain, the onset of rebound pain, (since performing SCB), the cumulative area under the curve of NRS pain severity scores through 48 hours postsurgery, postoperative opioid consumption at 48 hours postoperatively, onset and duration of the sensory blockade, onset and duration of the motor blockade and adverse reactions and adverse events. Patients will be followed-up to 48 hours postoperatively. Discussions: This protocol describes the design of a randomised controlled trial to evaluate the effect of different modes of administration of esketamine combined with SCB on the incidence of rebound pain after upper limb fracture surgery. The results may help to identify the most effective methods for managing pain in patients undergoing upper limb fracture surgery. Ethics and dissemination: This study has been approved by the Ethics Committee of the Deyang People’s Hospital (2023-03-010-K01). It was registered on the Chinese Clinical Trials Registry on 24 August 2023. We intend to publish the results in a peer-reviewed journal. Trial registration number: ChiCTR2300075083.

1 February 2025 in Therapeutics and Clinical Risk Management
Verified
Journal Article
Open access
PDF file
WJWencai Jiang
Wencai Jiang
XCXuemeng Chen
Xuemeng Chen
YPYanhua Peng
Yanhua Peng
WZWenhu Zhai
Wenhu Zhai
XZXianjie Zhang
Xianjie Zhang
RZRui Zhou
Rui Zhou
Background: Catheter-related bladder discomfort (CRBD) is a risk factor that impacts postoperative recovery and still troubles patients and healthcare staff. The present study is a bibliometric analysis of CRBD. Methods: The publications on CRBD were retrieved from the Web of Science Core Collection. VOSviewer and Excel were applied to present the current status and hot spots of CRBD research. We analyzed parameters such as the annual number of publications, countries/regions, organizations, authors, journals, and keywords of the articles in this area by generating visualization graphs. Results: A total of 127 articles were eligible, recorded by 78 journals, and drafted by 672 authors from 169 organizations in 26 countries/regions. The main type of these articles is randomized trial. Park Hee-Pyoung, Kim Hyun-Chang, and Cui Yuanshan are the most productive authors with 5 articles. Sichuan University, Seoul National University, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Capital Medical University, and Qingdao University published more articles on CRBD worldwide. China ranks No. 1 in terms of the number of publications, followed by South Korea and India. Journals specialized in anesthesiology, such as BMC Anesthesiology, Journal of Anesthesia, and British Journal of Anesthesia, are more popular with researchers in this area. The research hot spots of CRBD have concentrated on the prevention and treatment of CRBD. Conclusion: Though formal research on CRBD started late, there is a rising tendency for the number of publications. Authors and academic teams from Asia have made significant contribution to CRBD. Journals specialized in anesthesiology are priorities for publishing articles. Previous studies mainly focused on the pharmacological and pharmacological methods to CRBD. However, CRBD is not fully settled. Either clinical or experimental studies are still needed to further improve CRBD.

1 February 2025 in Medical Devices: Evidence and Research
Verified
Journal Article
Open access
PDF file
DXDongmei Xiang
Dongmei Xiang
LDLei Deng
Lei Deng
RZRui Zhou
Rui Zhou
XZXianjie Zhang
Xianjie Zhang
LTLei Tian
Lei Tian
YPYanhua Peng
Yanhua Peng
Introduction: Sedatives and anesthetics can modify airway tone and induce respiratory depression, exacerbating the gas exchange impairments associated with obesity. In obese patients undergoing gastrointestinal endoscopy, upper airway obstruction and hypoventilation are prevalent, leading to frequent occurrences of hypoxemia during the procedure. This study aims to investigate the effects of the nasopharyngeal airway in mitigating hypoxemia via alleviating upper airway obstruction in obese outpatients during painless gastrointestinal endoscopy procedure. Methods: This is a prospective single-center randomized controlled study. After signing the written informed consent, eligible outpatients scheduled for painless gastrointestinal endoscopy will be randomly allocated into the nasopharyngeal airway group (group N) and control group (group C), with 88 patients in each group. Patients in group N will undergo intubation of the nasopharyngeal airway prior to examination, whereas patients in group C will receive oxygen therapy through an endoscopic respiratory mask at a flow rate of 10 L/min during the procedure. All patients in two groups will receive propofol and opioids for procedural sedation. The primary outcome will be the incidence of hypoxemia. The secondary outcomes will be the incidence of epistaxis, suspended examination due to hypoxemia, manual ventilation, the times of attempt to nasopharynx airway insertion, duration of insertion of nasopharyngeal airway, tracheal/laryngeal mask intubation, adverse cardiovascular events, gastrointestinal complications, VAS score of nasopharynx pain after removing the nasopharyngeal airway, satisfaction score of patients, endoscopist and anesthesiologists. Discussion: This study evaluates the effects of nasopharyngeal airway insertion on hypoxemia caused by procedural sedation in obese patients undergoing gastrointestinal endoscopy. The results of this study are expected to provide evidence for the use of nasopharyngeal airway in obese outpatients. Trial Registration Number: ChiCTR2300078892.

25 March 2026 in World Journal of Public Health
Verified
Journal Article
Closed access
WYWeilin Yang
Weilin Yang
WJWencai Jiang
Wencai Jiang
Purpose: We aim to analyze the global and regional trends of the total disease burden and risk factors of diabetes. Methods: This study was based on the Global Burden of Disease (GBD) Study 2021. The global and regional trends of incidence, deaths, prevalence, and disability-adjusted life years (DALYs) were assessed. Level 2 risk factors in the database were included. Results: In 2021, global diabetes incidence, deaths, prevalence, and DALYs were 24,442.18 thousand, 1,656.63 thousand, 525,654.11 thousand, and 78,938.59 thousand, respectively. From 1990 to 2021, global age-standardized rates increased significantly, with average annual percent changes (AAPCs) of +1.71% (incidence), +0.14% (deaths), +2.05% (prevalence), and +0.94% (DALYs). Middle and low-middle social-demographic index (SDI) regions accounted for over half of the global burden across all metrics. Low-middle SDI regions had the fastest growth in death (AAPC: +1.05%) and DALYs rates (AAPC: +1,32%), while high SDI and high-middle regions showed a mortality decline (AAPC: -1.48% and -0.24%). In recent years, global age-adjusted incidence, prevalence, and DALYs rates of diabetes maintained positive APCs, with low-middle SDI regions leading in growth, while high SDI regions saw declining mortality and accelerated incidence, and middle SDI regions sustained steady growth across key metrics. High fasting plasma glucose, high body mass index, and dietary risks were still the top three risk factors. Conclusion: The global diabetes burden has continued to rise over the past three decades. Low-middle SDI regions have the fastest growth in death and DALYs rates, while low SDI regions maintain persistently high mortality and DALYs. In recent years, low-middle and middle SDI regions still face sustained growth of age-adjusted deaths, highlighting the need for targeted interventions.